| Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation D Li, J Liu, B Guo, C Liang, L Dang, C Lu, X He, HYS Cheung, L Xu, C Lu, ... Nature communications 7 (1), 10872, 2016 | 536 | 2016 |
| Ruthenium complexes as antimicrobial agents F Li, JG Collins, FR Keene Chemical Society Reviews 44 (8), 2529-2542, 2015 | 443 | 2015 |
| Recent progress in aptamer discoveries and modifications for therapeutic applications S Ni, Z Zhuo, Y Pan, Y Yu, F Li, J Liu, L Wang, X Wu, D Li, Y Wan, L Zhang, ... ACS Applied Materials & Interfaces 13 (8), 9500-9519, 2020 | 353 | 2020 |
| A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer F Li, J Lu, J Liu, C Liang, M Wang, L Wang, D Li, H Yao, Q Zhang, J Wen, ... Nature communications 8 (1), 1390, 2017 | 226 | 2017 |
| A mini-review for cancer immunotherapy: molecular understanding of PD-1/PD-L1 pathway & translational blockade of immune checkpoints Y Li, F Li, F Jiang, X Lv, R Zhang, A Lu, G Zhang International journal of molecular sciences 17 (7), 1151, 2016 | 195 | 2016 |
| Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma C Liang, F Li, L Wang, ZK Zhang, C Wang, B He, J Li, Z Chen, AB Shaikh, ... Biomaterials 147, 68-85, 2017 | 188 | 2017 |
| The antimicrobial activity of inert oligonuclear polypyridylruthenium (II) complexes against pathogenic bacteria, including MRSA F Li, Y Mulyana, M Feterl, JM Warner, JG Collins, FR Keene Dalton Transactions 40 (18), 5032-5038, 2011 | 138 | 2011 |
| Present advances and future perspectives of molecular targeted therapy for osteosarcoma AB Shaikh, F Li, M Li, B He, X He, G Chen, B Guo, D Li, F Jiang, L Dang, ... International journal of molecular sciences 17 (4), 506, 2016 | 131 | 2016 |
| In Vivo Delivery Systems for Therapeutic Genome Editing L Wang, F Li, L Dang, C Liang, C Wang, B He, J Liu, D Li, X Wu, X Xu, ... International journal of molecular sciences 17 (5), 626, 2016 | 120 | 2016 |
| Progress and challenges in developing aptamer-functionalized targeted drug delivery systems F Jiang, B Liu, J Lu, F Li, D Li, C Liang, L Dang, J Liu, B He, ... International journal of molecular sciences 16 (10), 23784-23822, 2015 | 97 | 2015 |
| In vitro susceptibility and cellular uptake for a new class of antimicrobial agents: dinuclear ruthenium(II) complexes F Li, M Feterl, Y Mulyana, JM Warner, JG Collins, FR Keene Journal of antimicrobial chemotherapy 67 (11), 2686-2695, 2012 | 96 | 2012 |
| RANKL/RANK system-based mechanism for breast cancer bone metastasis and related therapeutic strategies X Wu, F Li, L Dang, C Liang, A Lu, G Zhang Frontiers in cell and developmental biology 8, 76, 2020 | 90 | 2020 |
| PARP1 in carcinomas and PARP1 inhibitors as antineoplastic drugs L Wang, C Liang, F Li, D Guan, X Wu, X Fu, A Lu, G Zhang International journal of molecular sciences 18 (10), 2111, 2017 | 90 | 2017 |
| Chlorido-containing ruthenium (II) and iridium (III) complexes as antimicrobial agents M Pandrala, F Li, M Feterl, Y Mulyana, JM Warner, L Wallace, FR Keene, ... Dalton Transactions 42 (13), 4686-4694, 2013 | 87 | 2013 |
| Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer J Liu, D Li, L Dang, C Liang, B Guo, C Lu, X He, HYS Cheung, B He, B Liu, ... Scientific reports 7 (1), 40487, 2017 | 76 | 2017 |
| The rules and functions of nucleocytoplasmic shuttling proteins X Fu, C Liang, F Li, L Wang, X Wu, A Lu, G Xiao, G Zhang International journal of molecular sciences 19 (5), 1445, 2018 | 74 | 2018 |
| Protein binding by dinuclear polypyridyl ruthenium (II) complexes and the effect of cucurbit [10] uril encapsulation F Li, M Feterl, JM Warner, AI Day, FR Keene, JG Collins Dalton Transactions 42 (24), 8868-8877, 2013 | 69 | 2013 |
| Disorders of calcium and phosphorus metabolism and the proteomics/metabolomics-based research M Sun, X Wu, Y Yu, L Wang, D Xie, Z Zhang, L Chen, A Lu, G Zhang, F Li Frontiers in cell and developmental biology 8, 576110, 2020 | 62 | 2020 |
| Dinuclear ruthenium (II) antimicrobial agents that selectively target polysomes in vivo F Li, EJ Harry, AL Bottomley, MD Edstein, GW Birrell, CE Woodward, ... Chemical Science 5 (2), 685-693, 2014 | 59 | 2014 |
| Targeted delivery systems for molecular therapy in skeletal disorders L Dang, J Liu, F Li, L Wang, D Li, B Guo, X He, F Jiang, C Liang, B Liu, ... International journal of molecular sciences 17 (3), 428, 2016 | 46 | 2016 |
